Simultaneous enhancements of solubility and dissolution rate of poorly water-soluble febuxostat via salts

被引:17
|
作者
Zhang, Xian-Rui [1 ]
Zhang, Lei [1 ]
机构
[1] South China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China
关键词
Febuxostat; Di-2-pyridylamine; 2-Methylimidazole; Salt; X-ray diffraction; CRYSTAL-STRUCTURE; MULTICOMPONENT CRYSTALS; 3-DIMENSIONAL NETWORKS; HYDROGEN-BONDS; COCRYSTALS; COMPLEXES; 2-METHYLIMIDAZOLE; INHIBITOR; STABILITY; SOLVATE;
D O I
10.1016/j.molstruc.2017.02.052
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Novel crystalline forms of febuxostat (HFEB) salts were synthesized by liquid-assisted cogrinding with 2-methylimidazole (2MI) and di-2-pyridylamine (DPA) and characterized by Hirshfeld surface analysis, IR, H-1 NMR, single crystal and powder X-ray diffractions, TGA and DSC. Two new HFEB salts featured different stoichiometries: 2:1 molecular ratio in HFEB-2MI and 1:1 molecular ratio in HFEB-DPA. For HFEB-2MI salt, two HFEB molecules lost one proton forming a singly charged hydrogen carboxylate anion H(FEB)(2) over bar, which interacted with the disordered 2MI cation via the N3-H3A center dot center dot center dot O1(i) (i:-x,-y,-z+1) and N4-H4B center dot center dot center dot O1(ii)(ii: x, y+1, z-1) hydrogen bonds to form one-dimensional structure. For HFEB-DPA salt, one proton transferred from one HFEB to DPA, which were further connected by N4-H1 center dot center dot center dot O1 and N3-H2 center dot center dot center dot O2 hydrogen bonds to form an R-2 (2)(8) ring motif. HFEB-2M1 and HFEB-DPA salts exhibited increased equilibrium solubilities and intrinsic dissolution rates compared to those of HFEB in aqueous medium. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:328 / 334
页数:7
相关论文
共 50 条
  • [41] Oral formulation strategies to improve solubility of poorly water-soluble drugs
    Singh, Abhishek
    Worku, Zelalem Ayenew
    Van den Mooter, Guy
    EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (10) : 1361 - 1378
  • [42] Overview of milling techniques for improving the solubility of poorly water-soluble drugs
    Loh, Zhi Hui
    Samanta, Asim Kumar
    Heng, Paul Wan Sia
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 10 (04) : 255 - 274
  • [43] Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam
    Ambrus, R.
    Kocbek, P.
    Kristl, J.
    Sibanc, R.
    Rajko, R.
    Szabo-Revesz, P.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 381 (02) : 153 - 159
  • [44] THE INFLUENCE OF (MIXED) MICELLES ON THE DISSOLUTION KINETICS OF A POORLY WATER-SOLUBLE DRUG
    DESMIDT, JH
    OFFRINGA, JCA
    GRIT, M
    CROMMELIN, DJA
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1987, 9 (02) : 154 - 154
  • [45] The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs
    Park, Sung-Hyun
    Choi, Hoo-Kyun
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 321 (1-2) : 35 - 41
  • [46] Solubility, the Main Concern for Poorly Water-soluble Drugs: Techniques and Alternatives
    Singh, Komal
    Singh, Preet Amol
    Frank, Amanda
    Arora, Saahil
    Sharma, Rajiv
    Bajwa, Neha
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (12) : 2248 - 2260
  • [47] Effect of particle size on the dissolution behaviors of poorly water-soluble drugs
    Chu, Kyung Rok
    Lee, Eunhee
    Jeong, Seong Hoon
    Park, Eun-Seok
    ARCHIVES OF PHARMACAL RESEARCH, 2012, 35 (07) : 1187 - 1195
  • [48] Solubility Enhancement and Antioxidant Potential of Silymarin: A Poorly Water-soluble Drug
    Arora, Deepshi
    Taneja, Yugam
    Dhingra, Ashwani K.
    Guarve, Kumar
    Chauhan, Muskan
    Nagpal, Kajal
    CURRENT DRUG THERAPY, 2024, 19 (01) : 103 - 115
  • [49] Effect of particle size on the dissolution behaviors of poorly water-soluble drugs
    Kyung Rok Chu
    Eunhee Lee
    Seong Hoon Jeong
    Eun-Seok Park
    Archives of Pharmacal Research, 2012, 35 : 1187 - 1195
  • [50] SURFACTANT SOLUTIONS AS MEDIA FOR DISSOLUTION TESTING OF A POORLY WATER-SOLUBLE DRUG
    PANDIT, NK
    STRYKOWSKI, JM
    MCNALLY, EJ
    WALDBILLIG, AM
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1985, 11 (9-10) : 1797 - 1818